Cardiff Oncology, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CRDF Nasdaq 2836 www.cardiffoncology.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cardiff Oncology, Inc.

While institutions own 25% of Cardiff Oncology, Inc. (NASDAQ:CRDF), retail investors are its largest shareholders with 57% ownership - Dec 23rd, 2024 1:13 pm
Cardiff Oncology price target raised to $10 from $7 at Piper Sandler - Dec 14th, 2024 11:50 am
Cardiff Oncology Reports Promising Phase 2 Trial Results - Dec 11th, 2024 12:19 pm
Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering - Dec 10th, 2024 12:20 pm
Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial - Dec 10th, 2024 11:00 am
Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC - Nov 19th, 2024 1:00 pm
Cardiff Oncology Third Quarter 2024 Earnings: Beats Expectations - Nov 9th, 2024 1:17 pm
Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update - Nov 7th, 2024 9:05 pm
Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC - Oct 30th, 2024 8:30 pm
3 US Penny Stocks With Market Caps Over $40M - Oct 24th, 2024 5:06 pm
Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business Update - Aug 8th, 2024 8:05 pm
Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update - Aug 1st, 2024 8:05 pm
Companies Like Cardiff Oncology (NASDAQ:CRDF) Are In A Position To Invest In Growth - Jul 24th, 2024 1:30 pm
Cardiff Oncology to Present at the Jefferies Healthcare Conference - May 29th, 2024 8:05 pm
Cardiff Oncology to Present at Upcoming Investor Conferences in May - May 13th, 2024 8:05 pm
Cardiff Oncology First Quarter 2024 Earnings: Beats Expectations - May 4th, 2024 12:30 pm
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update - May 2nd, 2024 8:05 pm
Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update - Apr 25th, 2024 8:05 pm
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study - Apr 8th, 2024 8:05 pm
Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024 - Mar 6th, 2024 9:05 pm